Effectiveness of DiscontinuinG bisphosphonatEs Study: R21 Pilot Study

Completed · Phase 4

Conditions studied: Osteoporosis

In brief

This is a pilot study evaluating the recruitment strategies for sites and patients, data collection instruments, follow-up procedures, administrative processes, and the proposed management strategy for the future large scale national trial.

Key facts

Study ID

NCT02139007

Run by

University of Alabama at Birmingham

People needed

27

Starts

2014-06-01

Expected to finish

2016-07-01

Last updated by the study team

2017-05-12

Who can join

Age: 65 and older, up to 100. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Females 65+
• 3+ years of alendronate (Fosamax/Binosto) use
• Valid social security number

You may not qualify if…

• History of any other metabolic bone condition, such as Paget Disease of Bone
• Currently receiving treatment for ongoing cancer, excluding non-melanoma skin cancer.
• Has significant underlying illness that would be expected to prevent completion of the study (e.g., life-threatening disease likely to limit survival to less than 3 years)?
• HIV positive
• Involved in a conflicting (investigational drug) clinical trial

Where it is running

• University of Alabama at Birmingham — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.